(NSIS-B) Novonesis (Novozymes) - Ratings and Ratios

Novonesis A/S (CO:NSIS-B) is a global leader in biosolutions, specializing in the production and sale of industrial enzymes, functional proteins, and microorganisms. Headquartered in Bagsvaerd, Denmark, the company operates across multiple regions, including Europe, North America, Asia Pacific, the Middle East, Africa, and Latin America. Its product portfolio addresses a wide range of industries, including food and beverage, agriculture, animal health, and industrial cleaning.

In the food and beverage sector, Novonesis offers tailored solutions for dairy, baking, beverages, and plant-based products, enhancing efficiency and sustainability in food production. The company also provides enzyme solutions for agriculture, such as bioyield and biocontrol, designed to optimize crop yields and reduce environmental impact. Its industrial applications include drain openers, hygiene solutions, and professional laundry services, leveraging microbial and enzymatic technologies to deliver effective and eco-friendly outcomes.

Novonesis has a strong focus on innovation, with a diverse range of enzyme solutions, including corn and wheat separation, starch modification, and filtration processes. The company also addresses human health through solutions targeting brain, oral, and gastrointestinal well-being. Additionally, Novonesis provides biogas and renewable energy solutions, aligning with global sustainability goals.

Founded in 1925, Novonesis has established itself as a pioneer in the specialty chemicals industry, with a market capitalization of 192.011 billion DKK. The company’s financials indicate a price-to-earnings ratio of 59.50, with a forward P/E of 27.10, reflecting market expectations for future growth. Its return on equity stands at 12.67%, signaling efficient profitability.